Skip to content

Exploratory Study on the Anti-Aging Effects of a Test Food

Exploratory Study on the Anti-Aging Effects of a Test Food - Single-Arm, Open-Label Trial - - Exploratory Study on the Anti-Aging Effects of a Test Food - Single-Arm, Open-Label Trial -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059385
Enrollment
48
Registered
2025-12-07
Start date
2025-12-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Participants will take six capsules of the test food twice daily, in the morning and evening, with water or lukewarm water.

Sponsors

IMEQRD Co. Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy adults aged 40 to under 70 at the time of consent (2) Individuals who have received a thorough explanation of the study, fully understand its purpose and procedures, voluntarily wish to participate, and provide written informed consent

Exclusion criteria

Exclusion criteria: (1) Regular use (>=3 times/week) of specified health foods, functional foods, or supplements, or inability to discontinue such products even if used less than 3 times/week (e.g., NMN, vitamins A/B/C/D/E, DHA/EPA, sesamin, protein, etc.) (2) Currently receiving pharmacological treatment at the time of consent (excluding as-needed medications) (3) Excessive alcohol consumption (average >60g/day per week) (4) Difficulty with blood sampling (5) Unable to visit the study site (6) History or current serious disease of the heart, liver, kidneys, digestive system, etc. (7) Have received a vaccination within 1 month prior to the start of the study, or have a planned vaccination during the study period (8) Allergies to medications or foods (9) Participation in another clinical study of drugs or health foods, within 4 weeks after completion of such a study, or plans to participate in another study after consenting to this one (10) Blood component or 200 mL whole blood donation within 1 month before study start (11) 400 mL whole blood donation within 3 months before study start (12) Total blood drawn within 12 months prior to study start, including planned study draws, exceeds 1200 mL (13) Determined unsuitable for participation by the principal investigator

Design outcomes

Primary

MeasureTime frame
Biological age assessment using the Epigenetic Clock test

Secondary

MeasureTime frame
-Aging biomarkers (including NAD+, DHEA-S, 8-OHdG) -Questionnaire on aging-related factors

Countries

Japan

Contacts

Public ContactYoshitada Hira

IMEQRD Co., Ltd Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026